Authorea
Depends
Confidence: Medium
Researchers who want a free, Wiley-backed home for preprints and open data should use it.
New check
Comparison
Authorea lands on Depends, and Biorxiv lands on Worth it.
Researchers who want a free, Wiley-backed home for preprints and open data should use it.
Use bioRxiv if you're a life-sciences researcher who wants a free, fast, citable way to release a manuscript before journal review.
| Compare | ||
|---|---|---|
| Verdict | Depends | Worth it |
| Best for | Researchers posting free preprints | Life-sciences researchers pre-publication |
| Who it's not for | Teams wanting polished collaborative drafting . Overleaf is the community default | Clinical/medical research . use medRxiv instead |
| Privacy | No known public vulnerabilities found in the sources reviewed.10 | No breaches found; one open XSS report on the submission portal and a past Cloudflare outage. |
| Support quality | No support evidence found | No support evidence in sources |
| Public sentiment | Forum users find Authorea useful for preprinting and LaTeX collaboration but report journal-policy confusion, with many defaulting to Google Docs or Overleaf.⁶ | Researchers on Reddit and academic forums report broadly positive preprint experiences, with recurring worries about scooping and journal attitudes. |
| Biggest gotcha | Preprints go public fast; auto-publication has triggered desk rejections . verify target journal policy first⁵ | Site has gone fully offline before (Cloudflare outage); don't bet a deadline on uptime. |